San Francisco Sentry Investment Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $3K | Hold |
5
| – | – | ﹤0.01% | 610 |
|
|
2021
Q1 | $2K | Hold |
5
| – | – | ﹤0.01% | 686 |
|
|
2020
Q4 | $2K | Sell |
5
-53
| -91% | -$21.2K | ﹤0.01% | 652 |
|
|
2020
Q3 | $32K | Buy |
58
+2
| +4% | +$1.1K | 0.02% | 375 |
|
|
2020
Q2 | $35K | Buy |
56
+46
| +460% | +$28.8K | 0.02% | 367 |
|
|
2020
Q1 | $5K | Hold |
10
| – | – | ﹤0.01% | 559 |
|
|
2019
Q4 | $4K | Hold |
10
| – | – | ﹤0.01% | 659 |
|
|
2019
Q3 | $3K | Hold |
10
| – | – | ﹤0.01% | 693 |
|
|
2019
Q2 | $3K | Sell |
10
-7
| -41% | -$2.1K | ﹤0.01% | 697 |
|
|
2019
Q1 | $7K | Hold |
17
| – | – | ﹤0.01% | 593 |
|
|
2018
Q4 | $6K | Buy |
17
+4
| +31% | +$1.41K | ﹤0.01% | 609 |
|
|
2018
Q3 | $5K | Sell |
13
-622
| -98% | -$239K | ﹤0.01% | 654 |
|
|
2018
Q2 | $219K | Sell |
635
-454
| -42% | -$157K | 0.09% | 186 |
|
|
2018
Q1 | $375K | Buy |
1,089
+11
| +1% | +$3.79K | 0.11% | 180 |
|
|
2017
Q4 | $405K | Sell |
1,078
-251
| -19% | -$94.3K | 0.12% | 175 |
|
|
2017
Q3 | $594K | Buy |
1,329
+69
| +5% | +$30.8K | 0.2% | 118 |
|
|
2017
Q2 | $618K | Hold |
1,260
| – | – | 0.22% | 103 |
|
|
2017
Q1 | $488K | Buy |
1,260
+380
| +43% | +$147K | 0.27% | 92 |
|
|
2016
Q4 | $323K | Buy |
880
+300
| +52% | +$110K | 0.19% | 124 |
|
|
2016
Q3 | $233K | Buy |
+580
| New | +$233K | 0.14% | 149 |
|
|
2014
Q4 | – | Sell |
-265
| Closed | -$96K | – | 372 |
|
|
2014
Q3 | $96K | Sell |
265
-29
| -10% | -$10.5K | 0.05% | 226 |
|
|
2014
Q2 | $83K | Hold |
294
| – | – | 0.04% | 258 |
|
|
2014
Q1 | $88K | Buy |
294
+171
| +139% | +$51.2K | 0.03% | 287 |
|
|
2013
Q4 | $34K | Sell |
123
-1
| -0.8% | -$276 | 0.01% | 377 |
|
|
2013
Q3 | $39K | Hold |
124
| – | – | 0.01% | 339 |
|
|
2013
Q2 | $28K | Buy |
+124
| New | +$28K | 0.01% | 378 |
|